On-Demand version of the March 13, 2019 eCast.
Please note: This is a Single Viewer On-Demand eCast available for one registrant to access the on-demand version of the eCast. Once registered, access is granted via the AABB Education Website located at https://education.aabb.org.
Program Description: For many years, bacterial contamination of platelets has been a major medical and regulatory concern. With the development of several different platforms (FDA-approved pathogen reduction technology, FDA-approved point of release bacterial testing, and introduction of supplementary bacterial cultures performed by a transfusion service) that could be used to detect and/or limit exposure of patients to bacteria via platelets, the transfusion community is anticipating additional regulatory action/requirements from the FDA. This eCast will describe a number of approaches taken by hospitals to comply with the Draft FDA Guidance published in December 2018.
Please note: AABB plans to offer an eCast on Implementing the Final Guidance on Enhancing PLT Safety after the final guidance is released (final guidance expected late 2019; eCast expected in 2020).